455 related articles for article (PubMed ID: 30974290)
21. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.
Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W
J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797
[TBL] [Abstract][Full Text] [Related]
22. Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell pyroptosis via NLRP3-dependent pathway.
He D; Zhou M; Bai Z; Wen Y; Shen J; Hu Z
Biochem Biophys Res Commun; 2020 Jun; 526(3):772-779. PubMed ID: 32265028
[TBL] [Abstract][Full Text] [Related]
23. Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
Zheng G; Xu J; He F; Hu J; Ge W; Ji X; Wang C; Bradley JL; Peberdy MA; Ornato JP; Toldo S; Wang T; Tang W
Biomed Pharmacother; 2021 Nov; 143():112093. PubMed ID: 34474352
[TBL] [Abstract][Full Text] [Related]
24. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
Luo Y; Lu J; Ruan W; Guo X; Chen S
Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
[TBL] [Abstract][Full Text] [Related]
25. The NLRP3 inflammasome mediates DSS-induced intestinal inflammation in Nod2 knockout mice.
Umiker B; Lee HH; Cope J; Ajami NJ; Laine JP; Fregeau C; Ferguson H; Alves SE; Sciammetta N; Kleinschek M; Salmon M
Innate Immun; 2019 Feb; 25(2):132-143. PubMed ID: 30774010
[TBL] [Abstract][Full Text] [Related]
26. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Coll RC; Robertson AA; Chae JJ; Higgins SC; Muñoz-Planillo R; Inserra MC; Vetter I; Dungan LS; Monks BG; Stutz A; Croker DE; Butler MS; Haneklaus M; Sutton CE; Núñez G; Latz E; Kastner DL; Mills KH; Masters SL; Schroder K; Cooper MA; O'Neill LA
Nat Med; 2015 Mar; 21(3):248-55. PubMed ID: 25686105
[TBL] [Abstract][Full Text] [Related]
27. NLRP3 regulates alveolar bone loss in ligature-induced periodontitis by promoting osteoclastic differentiation.
Chen Y; Yang Q; Lv C; Chen Y; Zhao W; Li W; Chen H; Wang H; Sun W; Yuan H
Cell Prolif; 2021 Feb; 54(2):e12973. PubMed ID: 33382502
[TBL] [Abstract][Full Text] [Related]
28. The critical role of the hippocampal NLRP3 inflammasome in social isolation-induced cognitive impairment in male mice.
Niu L; Luo SS; Xu Y; Wang Z; Luo D; Yang H; Li W; He J; Zhong XL; Liu ZH; Zeng JY; Cao WY; Wan W
Neurobiol Learn Mem; 2020 Nov; 175():107301. PubMed ID: 32882398
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.
Primiano MJ; Lefker BA; Bowman MR; Bree AG; Hubeau C; Bonin PD; Mangan M; Dower K; Monks BG; Cushing L; Wang S; Guzova J; Jiao A; Lin LL; Latz E; Hepworth D; Hall JP
J Immunol; 2016 Sep; 197(6):2421-33. PubMed ID: 27521339
[TBL] [Abstract][Full Text] [Related]
31. Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis.
McElvaney OJ; Zaslona Z; Becker-Flegler K; Palsson-McDermott EM; Boland F; Gunaratnam C; Gulbins E; O'Neill LA; Reeves EP; McElvaney NG
Am J Respir Crit Care Med; 2019 Dec; 200(11):1381-1391. PubMed ID: 31454256
[No Abstract] [Full Text] [Related]
32. Nlrp3 Inflammasome Inhibitor MCC950 Ameliorates Obliterative Bronchiolitis by Inhibiting Th1/Th17 Response and Promoting Treg Response After Orthotopic Tracheal Transplantation in Mice.
Xu KY; Tong S; Wu CY; Ding XC; Chen JL; Ming Y; Wang SH
Transplantation; 2020 Jun; 104(6):e151-e163. PubMed ID: 32108749
[TBL] [Abstract][Full Text] [Related]
33. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J
Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832
[TBL] [Abstract][Full Text] [Related]
34. Activation of the NLRP3 Inflammasome Increases the IL-1β Level and Decreases GLUT4 Translocation in Skeletal Muscle during Insulin Resistance.
Américo-Da-Silva L; Aguilera J; Quinteros-Waltemath O; Sánchez-Aguilera P; Russell J; Cadagan C; Meneses-Valdés R; Sánchez G; Estrada M; Jorquera G; Barrientos G; Llanos P
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638553
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain.
Chen SP; Zhou YQ; Wang XM; Sun J; Cao F; HaiSam S; Ye DW; Tian YK
Pharmacol Res; 2019 Sep; 147():104339. PubMed ID: 31276771
[TBL] [Abstract][Full Text] [Related]
36. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
[TBL] [Abstract][Full Text] [Related]
37. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice.
Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA
J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388
[TBL] [Abstract][Full Text] [Related]
38. A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants.
Rieber N; Gavrilov A; Hofer L; Singh A; Öz H; Endres T; Schäfer I; Handgretinger R; Hartl D; Kuemmerle-Deschner J
Clin Immunol; 2015 Mar; 157(1):56-64. PubMed ID: 25596455
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
40. Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review.
Wu D; Chen Y; Sun Y; Gao Q; Li H; Yang Z; Wang Y; Jiang X; Yu B
Inflammation; 2020 Feb; 43(1):17-23. PubMed ID: 31646445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
